* Updated Keytruda (pembrolizumab) data in small cell lung
cancer and mesothelioma presented at 17th world conference on
lung cancer
The post BRIEF-Merck presents updated Keytruda data in small cell lung cancer and mesothelioma appeared first on NASDAQ.